Aging,inflammation, exercise, sarcopenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women above the age of 65; community-dwelling
Exclusion criteria
Exclusion criteria: Elderly people with cognitive impairment detectable by the Mini Mental State Examination, acute phase inflammatory disease, tumor growth in the last five years, current use of immunomodulating medications, amputation or lower limb fracture in the last 6 months, presence of any neurological disease and current participation in an alternative exercise programme.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma levels: interleukin-6 (IL-6), interleukin-10 (IL-10), soluble tumor necrosis factor alpha receptor-1 (sTNFR1), soluble tumor necrosis factor alpha receptor-2 (sTNFR2), Brain-Derived Neurotrophic Factor (BDNF) measured by ELISA method.;Functional capacity: timed up and go, Sit-to-stand test, 10-Meter Wlak Test;Single nucleotide polymorphism (SNP): TNF-alpha (rs1800629); IL6 (rs1800795), IL10 (rs1800896), BDNF (rs6265 and rs4923463) | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle strength: strength of the muscles in the knee joint measured by Biodex System 3 Pro ® isokinetic dynamometer (Biodex Medical Systems Inc., Shirley, NY, USA); hand grip, by JAMAR dynamometer (PC5030JI);Aerobic capacity: Six-Minute Walk Test (distance); Shuttle Walking Test (distance).;Allostatic load: by waist-hip ratio,salivary cortisol concentrations, Perceived Stress Scale, plasma levels of IL-6 and soluble tumor necrosis factor alpha receptor-1 (sTNFR1).;Depressive symptoms: Geriatric depression scale | — |
Countries
Brazil
Contacts
Escola de Educação Física, Fisioterapia e Terapia Ocupacional - UFMG